drugset / Trial / NCT01986283

Abuse Potential Study of PF-00345439

NCT01986283

Phase 1 Completed 67 enrolled Pain Therapeutics
RandomizedCrossoverDouble-blindBasic science

Summary

This study will determine the relative abuse potential of intact and chewed PF-00345439 (Oxycodone Extended-Release Capsules) compared to crushed oxycodone HCL immediate release (IR) tablets and placebo administered orally to non-dependent, recreational opioid users.

Timeline

Start
2013-11
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxycodone Other / unclassified 40 mg Oral